Blue dye could make thyroid cancer surgery safer and more effective
NCT ID NCT07354698
First seen Jan 22, 2026 · Last updated May 15, 2026 · Updated 19 times
Summary
This study tests whether injecting a blue dye (mitoxantrone) into the thyroid during robotic surgery helps surgeons remove more cancerous lymph nodes while protecting the parathyroid glands. About 114 adults with papillary thyroid cancer will be randomly assigned to get the dye or not. The goal is to see if the dye reduces accidental removal of parathyroid glands and improves cancer clearance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAPILLARY THYROID CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Daping Hospital
Chongqicun, 400042, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.